Patients With Cancer in the Countries of South-East Europe (the Balkans) Region and Prospective of the Particle Therapy Center: South-East European International Institute for Sustainable Technologies (SEEIIST)

Purpose: A recent initiative was launched for establishing the South-East European International Institute for Sustainable Technologies (SEEIIST), which will provide a cutting-edge Hadron radiation therapy treatment and research institute for treating cancer patients with Hadron therapy (HT). To jus...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mimoza M. Ristova, PhD, Vesna Gershan, PhD, Herwig Schopper, PhD, Ugo Amaldi, PhD, Manjit Dosanjh, PhD
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Medical physics. Medical radiology. Nuclear medicine R895-920 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/aa34380e913a4361ac7d8a2c70930097
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:aa34380e913a4361ac7d8a2c70930097
record_format	dspace
spelling	oai:doaj.org-article:aa34380e913a4361ac7d8a2c709300972021-11-06T04:33:05ZPatients With Cancer in the Countries of South-East Europe (the Balkans) Region and Prospective of the Particle Therapy Center: South-East European International Institute for Sustainable Technologies (SEEIIST)2452-109410.1016/j.adro.2021.100772https://doaj.org/article/aa34380e913a4361ac7d8a2c709300972021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2452109421001305https://doaj.org/toc/2452-1094Purpose: A recent initiative was launched for establishing the South-East European International Institute for Sustainable Technologies (SEEIIST), which will provide a cutting-edge Hadron radiation therapy treatment and research institute for treating cancer patients with Hadron therapy (HT). To justify the initiative for building the SEEIIST facility, a study was conducted to estimate the number of patients with cancer from the SEE region that would be eligible for HT. Methods and Materials: Two different methods for projecting the future annual cancer incidence have been applied: (1) using the International Agency on Research on Cancer@World Health Organization's (WHO) Globocan model which uses country's demographic factors, and (2) averaging the crude incidence data of 3 SEE countries with available national cancer registries, using a linear regression model of combined incidence per 100,000, and applying it to the entire SEE region. Cancer epidemiology data were collected and studied by using the countries’ cancer datasheets from WHO. The top 10 cancers were presented for the SEE region. Studies of other countries were used to develop a primordial model for estimating the number of SEE patients who could be treated most successfully with HT upon SEEIIST commissioning in 2030. Results: A model was developed to estimate the number of eligible patients for HT from SEE. It is estimated that 2900 to 3200 patients per year would be eligible for HT in the new SEEIIST facility in 2030. Conclusions: After commissioning, SEEIIST will initially treat approximately 400 patients per year, progressing toward 1000. Creation of SEEIIST dedicated patient selection criteria will be both necessary and highly challenging.Mimoza M. Ristova, PhDVesna Gershan, PhDHerwig Schopper, PhDUgo Amaldi, PhDManjit Dosanjh, PhDElsevierarticleMedical physics. Medical radiology. Nuclear medicineR895-920Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENAdvances in Radiation Oncology, Vol 6, Iss 6, Pp 100772- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medical physics. Medical radiology. Nuclear medicine R895-920 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Medical physics. Medical radiology. Nuclear medicine R895-920 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Mimoza M. Ristova, PhD Vesna Gershan, PhD Herwig Schopper, PhD Ugo Amaldi, PhD Manjit Dosanjh, PhD Patients With Cancer in the Countries of South-East Europe (the Balkans) Region and Prospective of the Particle Therapy Center: South-East European International Institute for Sustainable Technologies (SEEIIST)
description	Purpose: A recent initiative was launched for establishing the South-East European International Institute for Sustainable Technologies (SEEIIST), which will provide a cutting-edge Hadron radiation therapy treatment and research institute for treating cancer patients with Hadron therapy (HT). To justify the initiative for building the SEEIIST facility, a study was conducted to estimate the number of patients with cancer from the SEE region that would be eligible for HT. Methods and Materials: Two different methods for projecting the future annual cancer incidence have been applied: (1) using the International Agency on Research on Cancer@World Health Organization's (WHO) Globocan model which uses country's demographic factors, and (2) averaging the crude incidence data of 3 SEE countries with available national cancer registries, using a linear regression model of combined incidence per 100,000, and applying it to the entire SEE region. Cancer epidemiology data were collected and studied by using the countries’ cancer datasheets from WHO. The top 10 cancers were presented for the SEE region. Studies of other countries were used to develop a primordial model for estimating the number of SEE patients who could be treated most successfully with HT upon SEEIIST commissioning in 2030. Results: A model was developed to estimate the number of eligible patients for HT from SEE. It is estimated that 2900 to 3200 patients per year would be eligible for HT in the new SEEIIST facility in 2030. Conclusions: After commissioning, SEEIIST will initially treat approximately 400 patients per year, progressing toward 1000. Creation of SEEIIST dedicated patient selection criteria will be both necessary and highly challenging.
format	article
author	Mimoza M. Ristova, PhD Vesna Gershan, PhD Herwig Schopper, PhD Ugo Amaldi, PhD Manjit Dosanjh, PhD
author_facet	Mimoza M. Ristova, PhD Vesna Gershan, PhD Herwig Schopper, PhD Ugo Amaldi, PhD Manjit Dosanjh, PhD
author_sort	Mimoza M. Ristova, PhD
title	Patients With Cancer in the Countries of South-East Europe (the Balkans) Region and Prospective of the Particle Therapy Center: South-East European International Institute for Sustainable Technologies (SEEIIST)
title_short	Patients With Cancer in the Countries of South-East Europe (the Balkans) Region and Prospective of the Particle Therapy Center: South-East European International Institute for Sustainable Technologies (SEEIIST)
title_full	Patients With Cancer in the Countries of South-East Europe (the Balkans) Region and Prospective of the Particle Therapy Center: South-East European International Institute for Sustainable Technologies (SEEIIST)
title_fullStr	Patients With Cancer in the Countries of South-East Europe (the Balkans) Region and Prospective of the Particle Therapy Center: South-East European International Institute for Sustainable Technologies (SEEIIST)
title_full_unstemmed	Patients With Cancer in the Countries of South-East Europe (the Balkans) Region and Prospective of the Particle Therapy Center: South-East European International Institute for Sustainable Technologies (SEEIIST)
title_sort	patients with cancer in the countries of south-east europe (the balkans) region and prospective of the particle therapy center: south-east european international institute for sustainable technologies (seeiist)
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/aa34380e913a4361ac7d8a2c70930097
work_keys_str_mv	AT mimozamristovaphd patientswithcancerinthecountriesofsoutheasteuropethebalkansregionandprospectiveoftheparticletherapycentersoutheasteuropeaninternationalinstituteforsustainabletechnologiesseeiist AT vesnagershanphd patientswithcancerinthecountriesofsoutheasteuropethebalkansregionandprospectiveoftheparticletherapycentersoutheasteuropeaninternationalinstituteforsustainabletechnologiesseeiist AT herwigschopperphd patientswithcancerinthecountriesofsoutheasteuropethebalkansregionandprospectiveoftheparticletherapycentersoutheasteuropeaninternationalinstituteforsustainabletechnologiesseeiist AT ugoamaldiphd patientswithcancerinthecountriesofsoutheasteuropethebalkansregionandprospectiveoftheparticletherapycentersoutheasteuropeaninternationalinstituteforsustainabletechnologiesseeiist AT manjitdosanjhphd patientswithcancerinthecountriesofsoutheasteuropethebalkansregionandprospectiveoftheparticletherapycentersoutheasteuropeaninternationalinstituteforsustainabletechnologiesseeiist
_version_	1718443873467891712

Patients With Cancer in the Countries of South-East Europe (the Balkans) Region and Prospective of the Particle Therapy Center: South-East European International Institute for Sustainable Technologies (SEEIIST)

Ejemplares similares